首页/数据集/Expression data from FACS-sorted CD8+BTLA+ vs CD8+BTLA- Human Tumor-infiltrating Lymphocytes in Metastatic Melanoma

Expression data from FACS-sorted CD8+BTLA+ vs CD8+BTLA- Human Tumor-infiltrating Lymphocytes in Metastatic Melanoma

ChEBI2013-01-03 更新2026-07-21 收录

肿瘤浸润淋巴细胞

免疫检查点表达研究

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-43260 数据链接链接失效反馈

官方服务：

资源简介：

Expression data from FACS-sorted CD8+BTLA+ vs CD8+BTLA- Human Tumor-infiltrating Lymphocytes in Metastatic Melanoma

应用场景：

创建时间：

2013-01-03

膀胱癌免疫治疗

肿瘤浸润淋巴细胞

Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and plays a crucial role in bladder cancer (BCa). Several studies have shown the clinical significance of TIL in

NIAID Data Ecosystem70

Transcriptome analysis of tumor infiltrating NK and T cells in CT26-bearing BALB/C mice

肿瘤免疫学

肿瘤浸润淋巴细胞

CT26 tumors were implanted subcutaneously into syngeneic BALB/C mice and allowed to grow for 15-25 days. Tumors were collected, mechanically dissociated, and immune cells enriched using Percoll gradie

NIAID Data Ecosystem60

Levels of CD3, CD8 and CD20 TIL subpopulations.

肿瘤浸润淋巴细胞

肿瘤免疫组织化学

Data are reported as a percentage value of stroma TILs and are related to the sub-group assessed (CD3, CD8, CD20). For every antigen, two columns of values are reported, each corresponding to a differ

NIAID Data Ecosystem20

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis

乳腺癌预后

肿瘤浸润淋巴细胞

Background The prognostic values of tumor-infiltrating lymphocytes (TILs) and TILs subsets in breast cancer (BC) are uncertain. Methods A systematic literature search (MEDLINE, Web of Science, EMBASE,

NIAID Data Ecosystem70

Table_1_POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy.docx

子宫内膜癌免疫治疗生物标志物

肿瘤浸润淋巴细胞

ObjectiveAlthough Polymerase-epsilon (POLE)-mutated and mismatch repair (MMR)-deficient endometrial cancers (ECs) are considered as promising candidates for anti-PD-1/PD-L1 therapy, selecting only the

NIAID Data Ecosystem30

Expression data from FACS-sorted CD8+BTLA+ vs CD8+BTLA- Human Tumor-infiltrating Lymphocytes in Metastatic Melanoma

资源简介：

相关数据集